Why RxSight (RXST) Shares Are Falling
Why RxSight (RXST) Shares Are Falling
RxSight Inc (NASDAQ:RXST) shares are roughly flat following earlier weakness during Thursday's session after the company announced pricing of its $100 million proposed public offering of common stock.
RxSight Inc（納斯達克股票代碼：RXST）股價大致持平，此前該公司在週四的交易日宣佈了其1億美元普通股的擬議公開發行定價，此前該公司在週四的交易日出現疲軟。
The company plans to sell 1,785,714 shares of common stock at $56.00 per share, with an option for underwriters to purchase an additional 267,857 shares. Gross proceeds are estimated at around $100 million. The offering is expected to close on May 13.
該公司計劃以每股56.00美元的價格出售1,785,714股普通股，承銷商可以選擇額外購買267,857股股票。總收益估計約爲1億美元。此次發行預計將於5月13日結束。
BofA Securities is the lead bookrunning manager, with J.P. Morgan as a bookrunning manager and BTIG as co-manager. RxSight intends to use the proceeds for commercial expansion, international growth, product development, research and general corporate purposes.
美銀證券是首席賬面管理人，摩根大通擔任賬面管理人，BTIG擔任聯席經理。RxSight打算將所得款項用於商業擴張、國際增長、產品開發、研究和一般公司用途。
Should I Sell My RXST Stock?
我應該賣出我的 RXST 股票嗎？
Whether to sell or hold a stock largely depends on an investor's strategy and risk tolerance. Swing traders may sell an outperforming stock to lock in a capital gain, while long-term investors might ride out the turbulence in anticipation of further share price growth.
是賣出還是持有股票在很大程度上取決於投資者的策略和風險承受能力。波段交易者可能會出售表現跑贏大盤的股票以鎖定資本收益，而長期投資者可能會在股價進一步增長的預期下渡過難關。
Similarly, traders willing to minimize losses may sell a stock that falls a certain percentage, while long-term investors may see this as an opportunity to buy more shares at a discounted price.
同樣，願意最大限度地減少損失的交易者可能會賣出下跌一定百分比的股票，而長期投資者則可能將其視爲以折扣價購買更多股票的機會。
Shares of RxSight (NASDAQ:RXST) have gained 162.63% year to date. This compares to the average annual return of 55.93%, meaning the stock has outperformed its historical averages. Investors can compare a stock's movement to its historical performance to gauge whether this is a normal movement or a potential trading opportunity.
迄今爲止，RxSight（納斯達克股票代碼：RXST）的股價已上漲162.63％。相比之下，平均年回報率爲55.93％，這意味着該股的表現超過了歷史平均水平。投資者可以將股票的走勢與其歷史表現進行比較，以評估這是正常走勢還是潛在的交易機會。
Investors may also consider market dynamics. The Relative Strength Index can be used to indicate whether a stock is overbought or oversold. RxSight stock currently has an RSI of 71.81, indicating overbought conditions.
投資者也可以考慮市場動態。相對強弱指數可用於表明股票是超買還是超賣。RxSight股票目前的相對強弱指數爲71.81，這表明存在超買情況。
For analysis tools, charting data and access to exclusive stock news, check out Benzinga PRO. Try it for free.
RXST has a 52-week high of $66.54 and a 52-week low of $18.72.
如需分析工具、圖表數據和獲取獨家股票新聞，請查看 Benzinga PRO。免費試用。
RXST的52周高點爲66.54美元，52周低點爲18.72美元。
譯文內容由第三人軟體翻譯。